Natera, Inc. (NTRA) は上場企業です ヘルスケア セクターの Medical - Diagnostics & Research 業界で事業展開. 本社所在地は Austin, CA, アメリカ. 現CEOは Steven Leonard Chapman.
NTRA を有する IPO日 2015-07-01, 4,424 名の正社員, に上場 NASDAQ Global Select, 時価総額 $29.37B.
Natera, Inc. is a diagnostics company that develops and commercializes molecular testing services globally, serving the reproductive health, oncology, and transplant markets. Its core portfolio includes Panorama, a non-invasive prenatal test for chromosomal abnormalities; Horizon, a carrier screening test for genetic diseases; Spectrum, which identifies genetic conditions during in vitro fertilization; Anora, a miscarriage analysis test; and Signatera, a circulating tumor DNA technology for cancer screening and monitoring. The company also offers Constellation, a cloud-based software platform that enables laboratory partners to access its proprietary algorithms and bioinformatics. Natera commercializes its products through a direct sales force and a network of approximately 100 laboratory and distribution partners, supported by strategic partnerships with BGI Genomics and Foundation Medicine. Founded in 2003 and based in Austin, Texas, the company continues to expand its diagnostic capabilities across multiple clinical applications.
